Recurrent hepatitis C treatment with direct acting antivirals – a real life study at a Brazilian liver transplant center

Recurrent hepatitis C (HCV) after liver transplantation (LT) is an important cause of morbidity and mortality. Antiviral treatment is recommended to avoid unfavorable outcomes. Direct-acting antivirals (DAA) have transformed HCV treatment, with higher efficacy and fewer side-effects than interferon-...

Descripción completa

Detalles Bibliográficos
Autores principales: Zanaga, L.P., Santos, A.G., Ataíde, E.C., Boin, I.F.S.F., Stucchi, R.S.B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Brasileira de Divulgação Científica 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686270/
https://www.ncbi.nlm.nih.gov/pubmed/31389490
http://dx.doi.org/10.1590/1414-431X20198519

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686270/
https://www.ncbi.nlm.nih.gov/pubmed/31389490
http://dx.doi.org/10.1590/1414-431X20198519

Ejemplares similares